New data show that Canada losing the battle to attract new pharmaceutical R&D spending
Rx&D calls for new innovation strategy
The slide in R&D spending by Canadian pharma continues with 2004 expenditures by 84 reporting firms declining both in absolute dollars and research intensity. R&D spending as a percentage of revenue fell to 8.
Other stories mentioning these organizations, people and topics
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.